Technology
Cycurion – SUCCESS PAGE – April 21, 2026
Cycurion delivers a fully cloud-native, hardware-free security architecture that detects, mitigates, and neutralizes threats in real time
Cycurion delivers a fully cloud-native, hardware-free security architecture that detects, mitigates, and neutralizes threats in real time
Cycurion delivers a fully cloud-native, hardware-free security architecture that detects, mitigates, and neutralizes threats in real time
Building the digital infrastructure that is reshaping how intellectual property is valued, tracked, and monetized
Building the digital infrastructure that is reshaping how intellectual property is valued, tracked, and monetized
InCarda Therapeutics has created a new approach to treating A-fib at the moment patients need help most: when an episode begins
InCarda Therapeutics has created a new approach to treating A-fib at the moment patients need help most: when an episode begins
Ultrashort pulse lasers deliver intense bursts of energy and can destroy optical and infrared sensors on drones in less than a second
Ultrashort pulse lasers deliver intense bursts of energy and can destroy optical and infrared sensors on drones in less than a second
Vantis Vascular is developing breakthrough tools to deliver game-changing outcomes in advanced vascular intervention
AvenCell Therapeutics is pioneering the next generation of cancer treatment with powerful, persistent, and switchable allogeneic CAR-T therapies
AvenCell Therapeutics is pioneering the next generation of cancer treatment with powerful, persistent, and switchable allogeneic CAR-T therapies
Regenxbio [NASDAQ: RGNX] has three assets in pivotal trials with the potential to become standard of care in markets worth a total of $26B.